Gastrointestinal effectsparticularly nausea, vomiting, diarrhea, and constipationaffect 40-50% of patients, especially during dose escalation
Prior authorization is required your prescriber must document your qualifying CVD diagnosis and BMI
These figures show why the two vials are documented at different per-dose amounts: the 20 mg vial is set up to last far longer per vial
The expected approval and release date is unclear, with some reports saying late 2026 or early 2027, while others say 2028
If this is the case then you may consider switching to one of the covered medications
By understanding the anatomy of your skin, refining your injection technique, and being mindful of how certain medications and supplements affect your body, you can minimize these occurrences and focus on what truly matters: your health and vitality